Keywords: b-ms, gains, rights, uft, anticancer, drug, bristol-myers

B-MS Gains Rights To UFT Anticancer Drug

Article | 15 May 1995

Print This

Bristol-Myers Squibb has acquired exclusive rights in most world markets to UFT (tegafur and uracil), an anticancer product developed by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in